Thursday, December 23, 2021

Is the problem with cancer research THAT bad?

Mel,

During the summer I had breakfast with Azra Raza in New York City. Azra knows everyone in the cancer business. She's published in all the major journals like JAMA and Nature. She wrote "The First Cell" which is a scorching indictment of the whole cancer industry.

I asked: "Azra, is the cancer industry as corrupt as I think it is?"

Without missing a beat she replied, "Worse."

Two years ago I as an outsider came into the cancer field and saw:

  • They've got the wrong definition of cancer.

  • They're using the wrong definition of evolution (if they even think about evolution at all).

  • Their 'war on cancer' has been as successful as Vietnam.

  • They extend a patient's life by a mere 4 weeks and Wall Street pays them a billion dollars. They do victory laps while patients just suffer longer from their treatments.

  • People who are unquestionably doing breakthrough research that works can't get a dime.

  • 90% of the money gets poured into the abyss of late stage cancer even though 90% of the results come from early detection.

  • Early detection companies get bought by chemo companies because chemo is more profitable.

  • Somebody's got to do something about this.

The government is not going to solve this…The universities are not going to solve this...The FDA, the NIH, the CDC and the FTC aren't going to solve it.

So we must.

It's Tax Time.

Where Would You Rather Your Money Go?

To the corrupt cancer "industry" or to doctors and scientists doing the work that may lead to a REAL cure?

That's what Science Research 2.0 is all about.

Please go to www.evo2.org/cancer to help Azra and the rebels searching for a real cure now.

Seize the year,

Perry


***NOTE: This email address isn't monitored! If you need help, please email: support@perrymarshall.com

If you'd rather not receive any more emails from us, Unsubscribe

Perry S. Marshall & Assoc
805 Lake Street #295
Oak Park, Illinois 60301
United States
(312) 386-7459

No comments: